Akero rises on planned release of mid-stage data on liver disease asset
Akero grows with planned release of mid-stage data in liver disease assets
Report
Similar Posts
How safe is fluoride in drinking water? New study prompts more controversy.
© 2024 Fortune Media IP Limited. All rights reserved. Use of this site is accepted by…
Railroad operator CSX reaches five-year agreement with signalmen union
The CSX Railway Operator reaches a five-year contract with a signal union Report Thank you…
Forget the stock-market tumble — the Fed made the right move in a wild week
Well played? – Andrew Caballero-Reynolds/Agence France-Presse/Getty Images Federal Reserve Chairman Jerome Powell helped spark a tumultuous…
New inflation reading likely keeps the Fed on pause for now
Latest inflation data The Federal Reserve is likely to keep the rate on hold at its…
Meerut: 23-year-old unemployed and depressed man goes on slapping strangers on street for dopamine rush, arrested; Watch video here
A 23-year-old unemployed graduate from Meerut was arrested for allegedly slapping pedestrians, including a woman and…
Is AMD Stock a Buy Now?
Semiconductor designer Advanced Micro Devices (NASDAQ: AMD) has weakened recently. Although sharp jump in prices AMD…
English